Comparison of prochlorperazine and lorazepam antiemetic regimens in the control of postchemotherapy symptoms.

Author: MadsenR W, RhodesV A, SimmsS G

Paper Details 
Original Abstract of the Article :
This randomized, double-blind crossover study was undertaken to compare the antiemetic effectiveness of intravenous prochlorperazine (Compazine) and lorazepam (Ativan) in the management of postchemotherapy symptoms during two initial cycles of therapy. Each patient received at least one treatment as...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/8337162

データ提供:米国国立医学図書館(NLM)

Combatting Chemotherapy Side Effects: A Head-to-Head Comparison of Antiemetic Regimens

This randomized, double-blind crossover study compared the effectiveness of intravenous prochlorperazine and lorazepam in managing post-chemotherapy symptoms. The authors found that both regimens effectively controlled nausea and vomiting, but lorazepam significantly reduced overall symptom experience, particularly fatigue and pain. This study highlights the importance of considering individual patient needs and symptom profiles when selecting antiemetic regimens to optimize comfort and quality of life during chemotherapy.

Tailoring Antiemetic Therapies: A Personalized Approach

This study underscores the importance of personalized medicine in managing chemotherapy side effects. The authors' findings demonstrate the need for careful assessment of patient needs and symptom profiles when selecting antiemetic regimens, allowing for a more tailored approach to symptom management.

Managing Chemotherapy Side Effects: A Focus on Comfort

This study emphasizes the importance of improving the comfort and quality of life of patients undergoing chemotherapy. The authors' findings highlight the potential benefits of lorazepam in reducing overall symptom experience, potentially contributing to a more positive treatment experience.

Dr. Camel's Conclusion

This study offers a valuable roadmap for managing chemotherapy side effects, emphasizing the importance of individualized treatment plans and the potential benefits of lorazepam. Imagine a compassionate oasis in the desert of chemotherapy side effects, offering patients relief and improving their quality of life during treatment.

Date :
  1. Date Completed 1993-08-25
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

8337162

DOI: Digital Object Identifier

8337162

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.